TPDB

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB15285

Activity

Antibacterial Antifungal Hemolysis Toxicity

Activity_category_statistics

Anti-infective peptides Toxicity and safety peptides

Database_Source

dbAMP DRAMP Peptipedia CAFPdb PD_Hemolysis

Sequence_Type

standard

Has_Modification No

Description A 6-aa standard natural multi-activity (Antibacterial, Antifungal, Hemolysis, and other sources) peptide sequence curated from dbAMP, DRAMP, Peptipedia, and other sources, with an available 3D structural model.

Sequence

GLLKRI

FASTA

>TPDB15285|Antibacterial;Antifungal;Hemolysis;Toxicity|length=6
GLLKRI

Formula C32H62N10O7

Absent Amino Acids ANDCEQHMFPSTWYV

Common Amino Acids L

Mass 698.91

PI 11.49

Basic Residues 2

Acidic Residues 0

Hydrophobic Residues 3

Net Charge +2

Boman Index 0.38

Hydrophobicity 0.550

Aliphatic Index 195.00

Half Life

Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour

Extinction Coefficient Cystines 0

Absorbance 280nm 0.00

Polar Residues 0

number

0

A

1

R

0

N

0

D

0

C

0

E

0

Q

1

G

0

H

1

I

2

L

1

K

0

M

0

F

0

P

0

S

0

T

0

W

0

Y

0

V

Amino Acid Distribution

A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 2 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0

Length

6

Formula

C32H62N10O7

Mass

698.91

PI

11.49

Net Charge

+2

Boman Index

0.38

Hydrophobicity

0.550

Evidence 1 Activity

Activity

Activity Endpoint HC50

Detail Source Activity Hemolysis

Activity Measurement 7.51 µg/mL

Hemolysis Raw

[Ref.29614317] HC50=7.51µg/mL against human red blood cells

Target

RBC Target human red blood cells

Source & Reference

Database Source Hemolytik PD_Hemolysis

Source DRAMP4

Reference

Peptides. 2018 Jun 104:7-14.

Other

Source Activity Label	Source Definition
Hemolysis	Hemolytik experimentally validated hemolytic peptide annotation.

Evidence 2 Activity

Activity

Activity Endpoint 50% Hemolysis

Detail Source Activity Toxicity

Activity Measurement 7.51 µg/mL

Toxicity Type Hemolytic Cytotoxic

Toxicity Raw

50% Hemolysis | 7.51 | µg/mL | target cell: Human erythrocytes

Target

Target Cell Human erythrocytes

Source & Reference

Database Source NA

Source Database DBAASP

Reference

Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin. | Peptides | 2018

Evidence 3 Activity

Activity

Detail Source Activity Toxicity

Toxicity Type Hemolytic Cytotoxic

Toxicity Raw

- | NA | target cell: Human erythrocytes

Target

Target Cell Human erythrocytes

Source & Reference

Database Source NA

Source Database DBAASP

Reference

Structure-activity relationship study of anoplin. | J Pept Sci | 2005

Evidence 4 Activity

Activity

Activity Endpoint HC50

Detail Source Activity Toxicity

Activity Measurement 7.51 µg/mL

Toxicity Type Hemolytic

Toxicity Raw

Hemolytic_activity: [Ref.29614317] HC50=7.51µg/mL against human red blood cells

Target

Target Cell erythrocytes

Source & Reference

Database Source NA

Source Database DRAMP

Reference

Peptides. 2018 Jun 104:7-14.

Evidence 5 Hemolysis

Activity

Activity Measurement 7.51 µg/mL

Activity Endpoint HC50

Hemolysis Raw

[Ref.29614317] HC50=7.51µg/mL against human red blood cells

Detail Source Activity Hemolysis

Target

RBC Target human red blood cells

Source & Reference

source PD_Hemolysis

Reference

Peptides. 2018 Jun 104:7-14.

Source DRAMP4

Database Source PD_Hemolysis